Details for 2022180831

Up to date per 04.04.2026

Actions

Title / Product Name

RSV-IMMUNISIERUNGSTHERAPIE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2022180831

EP Publication Number

4144368

E-Number

1770013

Language

PCT Number

Publication Date

08.03.2023 A

26.02.2025 B1

Registration Date

26.02.2025

AT Publication Date

15.03.2025

Application Date

26.01.2012

Registration Number

Priorities

26.01.2011

201161436355 P

IPC

A61K 39/12 20060101AFI20230201BHEP

Maximum Duration of Protection

26.01.2032

Owner

GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE

Representative

No representatives present

Inventor

DORMITZER, Philip, R. Emeryville, CA 94662-8097US